81249-44-7Relevant articles and documents
SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE
-
Paragraph 00165-00166, (2021/05/07)
Disclosed are compounds and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, or tautomers thereof that may cause degradation of various proteins e.g., IKZF2 (Helios). Also disclosed are pharmaceutical compositions containing
LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF
-
Paragraph 00427, (2016/09/26)
Described herein are compounds that are LOXL2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with LOXL2 activity.